[ORGANIZATION]
Caliway Biopharmaceuticals
Featured in 3 tracked stories · first seen
Situations
CBL-514 clinical trials for fat reduction
3 clusters · 27 sources · last updated
Latest: CBL-514 injection shows potential to destroy fat cells
Clinical trials for an experimental injection known as CBL-514, developed by Caliway Biopharmaceuticals, have demonstrated potential in reducing visceral and subcutaneous fat. The treatment functions by inducing apoptosi
CBL-514 clinical trial results for obesity treatment
2 clusters · 6 sources · last updated
Latest: Caliway Biopharmaceuticals reports fat reduction with CBL-514
Clinical trials for CBL-514, an injectable drug developed by Caliway Biopharmaceuticals, have demonstrated potential in treating obesity by inducing apoptosis, or programmed cell death, in fat cells. Unlike traditional t